Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    NCGC00024840-07

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 65Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scisparc & Clearmind Collaborate On US Patent For Binge Behavior
    Scisparc & Clearmind Collaborate On US Patent For Binge Behavior

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169272/0/en/SciSparc-Clearmind-Collaboration-Leads-to-Publication-of-U-S-Patent-Application-Targeting-Binge-Behavior-Disorders.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    Clearmind Medicine Files US Patent For Metabolic Syndrome Treatment
    Clearmind Medicine Files US Patent For Metabolic Syndrome Treatment

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913567/0/en/Clearmind-Medicine-Announces-Submission-of-US-Patent-Application-for-Treating-Metabolic-Syndrome-and-Weight-loss.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Full Alliance Subsidiary DynaMAXX Launches PRiVIVE™ Topical Serum
    Full Alliance Subsidiary DynaMAXX Launches PRiVIVE™ Topical Serum

    18 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=878852&lang=en

    ACCESSWIRE
    18 Jun 2024
    Share Share
    FDA & Health Canada Clear IND for FSD to Proceed with PII Trial of FSD201
    FDA & Health Canada Clear IND for FSD to Proceed with PII Trial of FSD201

    06 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220906005664/en

    BUSINESSWIRE
    06 Sep 2022
    Share Share
    Lucid Psycheceuticals Files for Patent On Formulations of Palmitoylethanolamide
    Lucid Psycheceuticals Files for Patent On Formulations of Palmitoylethanolamide

    13 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220713005308/en

    BUSINESSWIRE
    13 Jul 2022
    Share Share
    FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial
    FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

    24 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210824005813/en

    BUSINESSWIRE
    24 Aug 2021
    Share Share